Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Patient preferences and cost-benefit of hypertension and hyperlipidaemia collaborative management model between pharmacies and primary care in Portugal: a discrete choice experiment alongside a trial (USFarmácia®)

  • At: Seville (Spain) (2022)
  • Type: Poster
  • Poster code: SAP-013
  • By: COSTA, Suzete (Institute for Evidence-Based Health (ISBE), Portugal)
  • Co-author(s): Dr Suzete Costa, Executive Director & Senior Research Director (Institute for Evidence-Based Health (ISBE), Lisboa, Portugal / Escola Nacional de Saúde Pública (ENSP), Universidade NOVA de Lisboa, Lisboa, Portugal)
    Mr José Guerreiro, Centre for Health Evaluation & Research (CEFAR) (Centre for Health Evaluation & Research (CEFAR), Infosaúde, Associação Nacional das Farmácias, Lisboa, Portugal)
    Ms Inês Teixeira (Centre for Health Evaluation & Research (CEFAR), Infosaúde, Associação Nacional das Farmácias, Lisboa, Portugal)
    Prof Dennis K Helling (Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Denver, United States)
    Prof Céu Mateus, Health Economics at Lancaster, Division of Health Research (Health Economics at Lancaster, Division of Health Research, Lancaster University, Lancaster, United Kingdom)
    Prof João Pereira (Centro de Investigação em Saúde Pública (CISP) and Comprehensive Health Research Centre (CHRC), Lisboa, Portugal)
  • Abstract:

    BACKGROUND INFORMATION: Little is known on patient preferences and value of pharmacy collaborative disease management with primary care using interprofessional communication technology-driven under real-world conditions. Discrete Choice Experiments (DCEs) are useful for quantifying preferences for nonmarket services.
    PURPOSE: 1) To explore..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses